At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Lactobacillus rhamnosus GGdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil After Randomized, Double-blind, Placebo-controlled Oral Administration
In Brief
A clinical study evaluating Lactobacillus rhamnosus GG for Upper Respiratory Infection and Acute Otitis Media. Completed, enrolled 40 participants.
Detailed Summary
The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUpper Respiratory Infection, Acute Otitis Media
Countries--
CollaboratorsFinnish Institute for Health and Welfare
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
Primary CompletionMay 2011
First PostedApr 2014
TodayJul 2026
First PostedApr 10, 2014
Enrollment StartJan 1, 2011
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.2 years ago
Interventions
Lactobacillus rhamnosus GGdietary